Public health policy and health economics
Public health policy and health economics: Invited Discussant 1110PD, 1111PD and 1112PD
Date
09 Sep 2017Session
Public health policy and health economicsPresenters
Francesco PerroneAuthors
F. PerroneAuthor affiliations
- Clinical Trials Unit, Istituto Nazionale Tumori – I.R.C.C.S - Fondazione Pascale, 80131 - Napoli/IT
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
4132 - Real-World Productivity, Healthcare Resource Utilization (HRU), and Quality of Life (QOL) in Patients with Advanced Gastric Cancer (GC) in Canada and Europe
Presenter: Gregory Maglinte
Session: Public health policy and health economics
Resources:
Abstract
Invited Discussant 1440PD, 1441PD and 1442PD
Presenter: Rosa Giuliani
Session: Public health policy and health economics
Resources:
Slides
Webcast
Invited Discussant 1113PD and 1444PD
Presenter: Matti Aapro
Session: Public health policy and health economics
Resources:
Slides
Webcast
1018 - Report on ESMO/SIOPE European Landscape project key results: Mapping the status and needs in AYA cancer care.
Presenter: Emmanouil Saloustros
Session: Public health policy and health economics
Resources:
Abstract
Slides
Webcast
2409 - Paediatric radiation therapy across Europe – a European questionnaire survey supported by the SIOPe, ESTRO, PROS and several national paediatric hematology-oncology societies (NAPHOS)
Presenter: charlotte demoor-goldschmidt
Session: Public health policy and health economics
Resources:
Abstract
1550 - Comparison of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) in Clinical Trials Supporting US Food and Drug Administration (FDA) Approval of Orphan vs. Non-orphan Drugs.
Presenter: Consolacion Molto Valiente
Session: Public health policy and health economics
Resources:
Abstract
Slides
Webcast
2429 - How to assess a cancer therapy? Feedback from the French HTA body on the ESMO-MCBS
Presenter: Mathilde Grande
Session: Public health policy and health economics
Resources:
Abstract
Slides
1743 - Clinical Benefit of Randomized Controlled Trials (RCT) Supporting US Food and Drug Administration (FDA) Conversion from Accelerated to Full Approval
Presenter: Maria Borrell Puy
Session: Public health policy and health economics
Resources:
Abstract
Slides
Webcast
Invited Discussant 1435O, 1436O and 1437O
Presenter: Carin Uyl-De Groot
Session: Public health policy and health economics
Resources:
Slides
Webcast
Invited Discussant 1438O and 1439O
Presenter: Paolo Bruzzi
Session: Public health policy and health economics
Resources:
Slides
Webcast